Summary & Overview
HCPCS C1607: Implantable Rechargeable Neurostimulator, Integrated
HCPCS Level II code C1607 identifies an integrated, rechargeable implantable neurostimulator system that includes all implantable and external components and the charging system. This device-level code matters nationally because implantable neurostimulation is an important therapeutic option for chronic pain, movement disorders, and other neurologic indications; precise coding supports device tracking, billing consistency, and payer coverage decisions.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how C1607 is defined, typical sites of service where the device is implanted and managed, and the clinical context for use. The publication summarizes available national benchmarks for device utilization and reimbursement trends, highlights recent policy and coverage considerations affecting implantable neurostimulation systems, and outlines common documentation and coding considerations relevant to billing and claims submission.
The content is intended for clinicians, billing professionals, and policy analysts seeking a national-level briefing on C1607: what the code represents, who pays for these devices, and which operational and policy issues to expect when billing for integrated, rechargeable implantable neurostimulators.
Billing Code Overview
HCPCS Level II code C1607 describes a neurostimulator, integrated (implantable), rechargeable with all implantable and external components including charging system. This device-level code represents a fully integrated, rechargeable implantable neurostimulation system that includes all internal components and any external charging equipment needed to power the implant.
-
Service type: Implantable neurostimulation device implantation and provision of the integrated rechargeable system
-
Typical site of service: Hospital inpatient or outpatient surgical settings and ambulatory surgical centers where implantable neuromodulation devices are placed and programmed
Clinical & Coding Specifications
Clinical Context
A 55-year-old patient with chronic, refractory neuropathic pain after failed conservative therapy undergoes implantation of a rechargeable, integrated implantable neurostimulator system. The multidisciplinary workflow begins with a neuromodulation consultation, psychological and pain assessments, and a temporary percutaneous trial neurostimulator. After a successful trial with ≥50% pain reduction, the patient is scheduled for permanent implantation of the integrated rechargeable system including implantable pulse generator, leads, and external charging system. Typical perioperative steps include preoperative device programming, implantation under general or monitored anesthesia care in an operating room or ambulatory surgical center, intraoperative fluoroscopic lead placement and testing, wound closure, and immediate postoperative device recharge education. Postoperative follow-up visits include wound checks, device interrogation and programming adjustments, and long-term recharge training and maintenance in the clinic or device manufacturer support centers.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
24 | Unrelated Evaluation and Management service by the same physician during a postoperative period | Use when a distinct E/M unrelated to the implant procedure is provided during global period |
25 |